<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NWS6QFW" height="0" width="0" style="display:none;visibility:hidden">

The Future of Biotech and Pharma Manufacturing: Part 2

Posted by Sandra Acosta
What does the future hold for biotech and pharma? Find out in part 2 of this blog series.

Read More »

Vendor Audit: What It Is and What to Expect From It

Posted by Nagadip Rao
EG Life Sciences explains the types of vendor audits that may happen in the pharmaceutical industry so programming teams can be prepared. Read more.

Read More »

Warp Speed, Vaccines, and Agile Practices

Posted by EG Life Sciences
Dr. Terry Barnhart uses the example of Operation Warp Speed and COVID-19vaccines to show how we can speed up pharmaceutical innovation. Learn more today!

Read More »

Tactics for Agile in Biopharma Research & Development

Posted by EG Life Sciences
A director of product management shares what works and what doesn't when implementing Agile within drug discovery organizations. Learn more today.

Read More »

Waterfall or Agile: Wrong Question!

Posted by Bob Ellis
Eliassen Group's Bob Ellis shares how to reframe your Agile approach. Start by empathizing with the audience, not focusing on a solution. Learn more.

Read More »

The Future of Biotech and Pharma Manufacturing

Posted by Sandra Acosta
Follow Sandra Acosta, Director of Biopharma Solutions, as she considers the difference between biotech and pharma and what's next for these industries.

Read More »

Scrumming Scientific Project Management

Posted by EG Life Sciences
Scientist and Agilist Kendra West shares tips for introducing Agile practices within scientific project management. Learn from her findings today.

Read More »

Pharmaceutical Innovation and Agility

Posted by EG Life Sciences
Dr. Terry Barnhart shares how your company can boost innovation through Agile pharmaceuticals. Start accelerating your innovation today.

Read More »

Behind the Scenes: The Production of Viral Vector Vaccines

Posted by Sandra Acosta
Have you ever wondered what goes into the production of viral vector vaccines? Read on.

Read More »

What are Viral Vectors and How Do They Work?

Posted by Sandra Acosta
In this blog post, Sandra Acosta answers timely questions in the life sciences space: What are viral vectors? And how do the types of viral vectors work?

Read More »

Cell Gene Therapy and Viral Vectors: How Can They Be Effective for Compromising Diseases and COVID-19?

Posted by Sandra Acosta
With new technologies like cell gene therapy and viral vectors, we have a better chance of beating COVID-19 and serious diseases. Learn more here.

Read More »

Automation for Continuous Compliance in BioPharma and Life Sciences

Posted by Jim Damato
Eliassen Group experts talk about the impact of automation on continuous compliance, which can lead to savings and an improvement in outcomes.

Read More »

Viral Controls and Prevention of Cross-Contamination in the Vaccine Industry

Posted by Sandra Acosta
Sandra Acosta shares the steps that industries can follow to improve safety within the vaccine industry. Read more.

Read More »

Celebrating Eliassen Group’s Brand Evolution and Expanded Service Offerings

Posted by EG Life Sciences
EG Life Sciences is sharing the news of Eliassen Group’s updated brand. Read more about what this means for us – and our clients.

Read More »

Sources of Cross-Contamination in Vaccine Production

Posted by Sandra Acosta
In the vaccine production process, protecting against foreign matter is crucial. Learn about sources of contamination in vaccines so you can avoid them.

Read More »

Subscribe to our Blog